Sarepta Therapeutics (SRPT) Other Gross PP&E Adjustments (2016 - 2025)
Sarepta Therapeutics (SRPT) has 15 years of Other Gross PP&E Adjustments data on record, last reported at -$158.0 million in Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments fell 12.13% year-over-year to -$158.0 million; the TTM value through Dec 2025 reached -$27.0 million, down 106.62%, while the annual FY2024 figure was $408.5 million, 50.74% up from the prior year.
- Other Gross PP&E Adjustments reached -$158.0 million in Q3 2025 per SRPT's latest filing, up from -$169.7 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $408.5 million in Q4 2024 and bottomed at -$170.6 million in Q1 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$28.2 million, with a median of -$81.5 million recorded in 2021.
- Peak YoY movement for Other Gross PP&E Adjustments: soared 51.32% in 2021, then tumbled 176.7% in 2023.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $248.9 million in 2021, then rose by 1.21% to $251.9 million in 2022, then grew by 7.58% to $271.0 million in 2023, then surged by 50.74% to $408.5 million in 2024, then crashed by 138.68% to -$158.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$158.0 million in Q3 2025, -$169.7 million in Q2 2025, and -$170.6 million in Q1 2025.